Genzyme receives positive CHMP opinion for LEMTRADA™ in Europe
"Today’s CHMP opinions set the stage for the approval of…
28 June 2013 | By Sanofi
"Today’s CHMP opinions set the stage for the approval of two important new treatment options..."
List view / Grid view
"Today’s CHMP opinions set the stage for the approval of…
28 June 2013 | By Sanofi
"Today’s CHMP opinions set the stage for the approval of two important new treatment options..."
Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS…
31 October 2012 | By
Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications...
The Phase lll CARE-MS ll trial met both of its…
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...
New results from the CARE-MS I trial...
22 October 2011 | By Sanofi
New results from the CARE-MS I trial...
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...